Table 3 Summary of any grade treatment-related adverse events reported in at least 10% of participants
Adverse events | All participants (n = 47) n (%) | |
|---|---|---|
All grades | Grades ≥3 | |
Diarrhoea | 19 (40) | 0 (0) |
Fatigue | 18 (38) | 1 (2) |
Acneiform rash | 18 (38) | 0 (0) |
Cough | 17 (36) | 0 (0) |
Headache | 17 (36) | 2 (4) |
Back pain | 16 (34) | 1 (2) |
Musculoskeletal and connective tissue disorder | 15 (32) | 1 (2) |
Nausea | 14 (30) | 2 (4) |
Pain | 14 (30) | 1 (2) |
Skin and subcutaneous tissue disorders | 13 (28) | 0 (0) |
